Discovering dominant tumor immune archetypes in a pan-cancer censusTumors can be extremely heterogenous across multiple parameters. By identifying and classifying recurrent immune features across 12 different tumor types, a framework is provided toward understanding tumor immunity as well as identifying broad and common therapeutic targets.Tumors can be extremely heterogenous across multiple parameters. By identifying and classifying recurrent immune features across 12 different tumor types, a framework is provided toward understanding tumor immunity as well as identifying broad and common therapeutic targets.Alexis J. Combes, Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder, Divyashree Kushnoor, Alan Shen, Brittany Davidson, Andrea J. Barczak, Michael Adkisson, Austin Edwards, Mohammad Naser, Kevin C. Barry, Tristan Courau, Taymour Hammoudi, Rafael J. Argüello, Arjun Arkal Rao, Adam B. Olshen, The Immunoprofiler Consortium, Cathy Cai, Jenny Zhan, Katelyn C. Davis, Robin K. Kelley, Jocelyn S. Chapman, Chloe E. Atreya, Amar Patel, Adil I. Daud, Patrick Ha, Aaron A. Diaz, Johannes R. Kratz, Eric A. Collisson, Gabriela K. Fragiadakis, David J. Erle, Alexandre Boissonnas, Saurabh Asthana, Vincent Chan, Matthew F. Krummelhttps://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901426-4%3Frss%3Dyes&rc=0http://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignDecember 28, 2021

Powered by WPeMatico